Publication:
Correction to: Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children (Clinical Pharmacokinetics, (2019), 58, 1, (53-61), 10.1007/s40262-018-0658-1)

dc.contributor.authorSophida Boonsathornen_US
dc.contributor.authorIek Chengen_US
dc.contributor.authorFrank Kloproggeen_US
dc.contributor.authorCarlos Alonsoen_US
dc.contributor.authorCharmion Leeen_US
dc.contributor.authorBilyana Donchevaen_US
dc.contributor.authorJohn Boothen_US
dc.contributor.authorRobert Chiesaen_US
dc.contributor.authorAdam Irwinen_US
dc.contributor.authorJoseph F. Standingen_US
dc.contributor.otherUniversity of Queensland, Centre for Clinical Researchen_US
dc.contributor.otherUniversity of Londonen_US
dc.contributor.otherUCLen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.contributor.otherUCL Institute of Child Healthen_US
dc.date.accessioned2020-01-27T10:12:45Z
dc.date.available2020-01-27T10:12:45Z
dc.date.issued2019-01-17en_US
dc.description.abstract© 2018, The Author(s). The Open Access license, which previously read: Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creat iveco mmons .org/licen ses/ by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. Should read: Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.en_US
dc.identifier.citationClinical Pharmacokinetics. Vol.58, No.1 (2019), 141en_US
dc.identifier.doi10.1007/s40262-018-0722-xen_US
dc.identifier.issn11791926en_US
dc.identifier.issn03125963en_US
dc.identifier.other2-s2.0-85058685393en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/51958
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85058685393&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleCorrection to: Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children (Clinical Pharmacokinetics, (2019), 58, 1, (53-61), 10.1007/s40262-018-0658-1)en_US
dc.typeErratumen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85058685393&origin=inwarden_US

Files

Collections